Order of the President of the General Court of 20 July 2016 — PTC Therapeutics International Ltd v EMA

(Case T-718/15 R)

((Application for interim measures - Access to documents - Regulation (EC) No 1049/2001 - Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market - Decision to grant a third party access to the documents - Application for suspension of operation of a measure - Urgency - Prima facie case - Weighing up of interests))

(2016/C 326/48)

Language of the case: English

Parties

Applicant: PTC Therapeutics International Ltd (Dublin, Ireland) (represented by: G. Castle, B. Kelly, H. Billson, Solicitors, M. Demetriou, QC, and C. Thomas, Barrister)

Defendant: European Medicines Agency (represented by: T. Jabłoński, A. Spina, A. Rusanov, S. Marino and N. Rampal Olmedo, Agents)

Intervener in support of the applicant: European Confederation of Pharmaceutical Entrepreneurs (Eucope) (Brussels, Belgium) (represented by: S. Cowlishaw, Solicitor, and D. Scannell, Barrister)

Re:

Application pursuant to Articles 278 TFEU and 279 TFEU for, in essence, the suspension of operation of Decision EMA/722323/2015 of the EMA of 25 November 2015, granting to a third party, pursuant to Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to certain documents containing information submitted in the context of an application for marketing authorisation for the medicinal product Translarna.

Operative part of the order